Tag: trastuzumab

Living Longer: Advanced Breast Cancer (ABC) – HER2 over-expressed (1st line treatments)

Living Longer: Advanced Breast Cancer (ABC) – HER2 over-expressed (1st line treatments)

Introduction HER2 over-expression constitutes around 20% of all breast cancer. Two different methods are being used to test for HER2 over-expression, immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) Immunohistochemistry (IHC); identifies HER2 expression on the cell surface, with a grading system of 0 to 3+ positive. tumors are classed as HER2-positive if they have … Continue reading Living Longer: Advanced Breast Cancer (ABC) – HER2 over-expressed (1st line treatments)